Jana FischerCEO and Co-Founder at Navignostics AGSpeaker
Profile
**Dr. Jana Fischer** is a scientist-entrepreneur with a deep background in computational biology and a passion for advancing precision oncology. She earned her PhD at the University of Zurich under Prof. Bodenmiller, where she specialized in spatial proteomic characterization of tumor ecosystems. Her research, which focused on unraveling the complex interactions between tumor and immune cells and their impact on patient outcomes, was published in top-tier scientific journals, including Nature. In 2022, Jana co-founded Navignostics, aiming to revolutionize cancer diagnostics by introducing the world’s first spatial proteomic test to inform personalized cancer treatment decisions. Under her leadership as CEO, Navignostics has achieved remarkable milestones in company development, assembling a dynamic team and robust support network that are driving the transformation of precision oncology to advance patient care worldwide.
